Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuroimmunology

• Publication date

  2009-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2008.11.011PMID 19174309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guillain-Barré Syndrome

  2012cited by this paper
• The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.

  2007cited by this paper
• The Effects of Dehydroepiandrosterone (DHEA) on In Vitro Spleen Cell Proliferation and Cytokine Production

  2006cited by this paper
• Anti‐inflammatory and Immune Regulatory Properties of 5‐Androsten‐3β, 17β‐Diol (HE2100), and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases

  2005cited by this paper
• Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders.

  2005cited by this paper
• SeminarGuillain-Barré syndrome

  2005cited by this paper
• Guillain-Barré syndrome

  2004cited by this paper
• A synthetic androstene analogue inhibits collagen-induced arthritis in the mouse.

  2004cited by this paper
• Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA)

  2004cited by this paper
• Serum tumour necrosis factor‐α and soluble tumour necrosis factor receptors levels in patients with Guillain–Barre syndrome

  2004cited by this paper
• A novel therapy for acute hepatitis utilizing dehydroepiandrosterone in the murine model of hepatitis.

  2004cited by this paper
• Dehydroepiandrosterone Therapy Ameliorates Experimental Autoimmune Myasthenia Gravis in Lewis Rats

  2003cited by this paper
• Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.

  2002cited by this paper
• A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.

  2002cited by this paper
• Animal models of immune-mediated neuropathies

  2002influential reference
• Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.

  2002cited by this paper
• Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis

  2001cited by this paper
• Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha.

  2001cited by this paper
• Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy.

  2001cited by this paper
• Stimulation of Th2 Response by High Doses of Dehydroepiandrosterone in KLH-Primed Splenocytes

  2001cited by this paper
• Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.

  2001cited by this paper
• Administration of Dehydroepiandrosterone Suppresses Experimental Allergic Encephalomyelitis in SJL/J Mice

  2001cited by this paper
• Suppression of Autoimmune Neuritis in IFN-γ Receptor-Deficient Mice

  2001cited by this paper
• Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases – substitutes of adrenal and sex hormones

  2000cited by this paper
• Attenuation of house dust mite Dermatophagoides farinae‐induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down‐regulation of TH2 response

  1999cited by this paper
• Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor α and Interlukin‐6 in astrocytes

  1999cited by this paper
• Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 [correction of interlukin-6] in astrocytes.

  1999cited by this paper
• Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

  1998cited by this paper
• Elevated serum levels of IFN-γ, IL-4 and TNF-α/ unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage

  1998cited by this paper
• Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.

  1998cited by this paper
• Recovery from Guillain-Barré syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma.

  1998cited by this paper
• Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome.

  1998cited by this paper
• The Actions of Exogenous Dehydroepiandrosterone in Experimental Animals and Humans

  1998cited by this paper
• Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice.

  1998cited by this paper
• Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome.

  1997cited by this paper
• Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor.

  1995cited by this paper
• MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION 1

  1973cited by this paper

• Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis

  2025cites this paper
• Serum steroid metabolome pattern is associated with the response to prednisolone therapy of male patients with IgA nephropathy

  2025cites this paper
• Effect of Treatment on Steroidome in Women with Multiple Sclerosis

  2025cites this paper
• The Effects of Neuroactive Steroids on Myelin in Health and Disease

  2024cites this paper
• Altered Steroidome in Women with Multiple Sclerosis

  2024cites this paper
• Steroidomics in Men with Schizophrenia

  2024cites this paper
• Association between Disgust Sensitivity during Pregnancy and Endogenous Steroids: A Longitudinal Study

  2024cites this paper
• Glucocorticoids and Dehydroepiandrosterone: A Role in Immunosenescence?

  2019cites this paper
• Neuroendocrine and inflammatory responses to DHEA administration in young healthy women

  2018influential citation
• Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.

  2017cites this paper
• Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?

  2017cites this paper
• An exploratory pilot investigation of neurosteroids and self-reported pain in female Iraq/Afghanistan-era Veterans.

  2016cites this paper
• New Strategies in the Management of Guillain–Barré Syndrome

  2014cites this paper
• The Role of Stress and Adrenal Hormones in Immunosenescence

  2013cites this paper
• The Strategies Used for Treatment of Experimental Autoimmune Neuritis (EAN): A Beneficial Effect of Glatiramer Acetate Administered Intraperitoneally

  2012cites this paper
• Neuroprotective and Neurogenic Properties of Dehydroepiandrosterone and its Synthetic Analogs

  2011cites this paper
• Forced-Exercise Dependent Changes in Cellular Immunity: Effects on Experimental Autoimmune Neuritis

  2011cites this paper
• Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments.

  2011cites this paper